Back to search

Article

Analytical Performance of the Point-of-care BIOSYNEX COVID-19 Ag BSS for the Detection of SARS‐CoV‐2 Nucleocapsid Protein in Nasopharyngeal Swabs: A Prospective Field Evaluation During the COVID-19 Third Wave in France

2021-09-16

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> The accuracy and reliability of rapid diagnostic tests are critical for monitoring and diagnosing SARS-CoV-2 infection in the general population. This study aimed to evaluate the analytical performance of the <italic>BIOSYNEX COVID-19 Ag BSS</italic> (Biosynex Swiss SA, Fribourg, Switzerland) antigen rapid diagnostic test (Ag-RDT), which targets the SARS-CoV-2 N...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5da903fc-feb5-5c28-b9f2-70e1ee61c4aa
DOI
10.21203/rs.3.rs-876550/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Analytical Performance of the Point-of-care BIOSYNEX COVID-19 Ag BSS for the Detection of SARS‐CoV‐2 Nucleocapsid Protein in Nasopharyngeal Swabs: A Prospective Field Evaluation During the COVID-19 Third Wave in FranceDOI 10.21203/rs.3.rs-876550/v1
Select a neighboring publication to make it the new centre.